N@N

BioElectronics Receives New OTC Product Approvals

^{Published on 2010-06-29 06:11:44 - Market Wire}
 

FREDERICK, MD--(Marketwire - June 29, 2010) - BioElectronics Corporation (PINKSHEETS: [ BIEL ]), developers of innovative pain-relieving medical devices, announced today that its Allay™ Menstrual Pain Therapy product has been approved for over the counter sale by Health Canada for the treatment of menstrual pain symptoms, including cramps and abdominal pain, and for reducing the use of pain medication associated with menstruation, while ActiPatch™ is now approved by the South Korea Food and Drug Administration (KFDA) for reduction of muscle pain.

The new approvals of our technology in these two markets build upon the growing momentum of global expansion for BioElectronics' unique pain-relieving technology. Additionally, the Company recently secured an agreement for distribution of its products in Russia.

The Allay and ActiPatch products provide a safe, drug-free treatment for pain suffered by millions of people through the use of innovative pulse electromagnetic energy technology to reduce inflammation, edema and pain.

"With its proven technology and established clinical platform, Allay and ActiPatch are very unique brands in both Canada and Korea," said Arnon Horev, Vice President of Sales and Marketing with BioElectronics. "These latest approvals open the door to new markets for our products and will allow us to further expand access to these effective, safe topical and drug-free options for pain relief."

BioElectronics' unique technology is marketed under several brands to provide welcome relief and accelerate healing from pain and discomfort due to a variety of musculoskeletal disorders and rehabilitation. Already available in more than 44 countries worldwide, the clinically proven anti-inflammatory and pain relief therapy products utilize widely recognized pulse electromagnetic technology to deliver safe and effective electromagnetic energy to treat a wide variety of inflammatory, edema and pain conditions, including post-operative surgical therapy.

For more information about BioElectronics' innovative pulse electromagnetic therapy devices, visit [ www.bielcorp.com ].

About BioElectronics Corporation
BioElectronics Corporation (PINKSHEETS: [ BIEL ])is the maker of safe, inexpensive, drug-free medical devices and patches that deliver pulsed electromagnetic energy to relieve pain and inflammation. The Company's wafer thin patches contain an embedded microchip and battery that deliver pulsed electromagnetic energy, a clinically proven and widely accepted anti-inflammatory and pain relief therapy that heretofore has only been possible to obtain from large, facility-based equipment. BioElectronics markets and sells its current products under the brand names ActiPatch™, RecoveryRx™, Allay™ Menstrual Pain Therapy and HealFast™ Therapy for cats, dogs and horses. The Company is headquartered in Frederick, MD. For more information, visit [ www.bielcorp.com ].